Celularity Inc. Proceeds from Issuance of Private Placement
Celularity Inc. (CELU) reported Proceeds from Issuance of Private Placement of $1.01 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-08-29
- Celularity Inc. proceeds from issuance of private placement for the quarter ending 2024-12-31 was $0.00.
- Celularity Inc. proceeds from issuance of private placement for the quarter ending 2024-09-30 was $0.00.
- Celularity Inc. proceeds from issuance of private placement for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Celularity Inc. proceeds from issuance of private placement for the quarter ending 2024-03-31 was $6.00M, a 33.33% decline year-over-year.
- Celularity Inc. proceeds from issuance of private placement for fiscal 2024 was $6.00M, a 52.94% decline from fiscal 2023.
- Celularity Inc. proceeds from issuance of private placement for fiscal 2023 was $12.75M, a 57.50% decline from fiscal 2022.
- Celularity Inc. proceeds from issuance of private placement for fiscal 2022 was $30.00M, a 64.03% decline from fiscal 2021.
- Celularity Inc. proceeds from issuance of private placement for fiscal 2021 was $83.40M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2025-06-30 | $1.01M 10-Q · filed 2025-08-29 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | $6.00M 10-K · filed 2025-05-08 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-06 | $0.00 derived: sum of 2 quarters · filed 2024-12-06 | $6.00M 10-Q · filed 2024-12-06 | $6.00M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $6.00M 10-Q · filed 2024-11-07 | $6.00M derived: sum of 3 quarters · filed 2025-05-08 | $6.00M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $6.00M 10-Q · filed 2024-10-16 | $6.00M derived: sum of 2 quarters · filed 2025-05-08 | $6.00M derived: sum of 3 quarters · filed 2025-05-08 | $9.75M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $3.75M derived: sum of 3 quarters · filed 2025-05-08 | $12.75M 10-K · filed 2025-05-08 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-06 | $3.75M derived: sum of 2 quarters · filed 2024-12-06 | $12.75M 10-Q · filed 2024-12-06 | $12.75M derived: sum of 4 quarters · filed 2024-12-06 |
| 2023-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $12.75M 10-Q · filed 2024-11-07 | $12.75M derived: sum of 3 quarters · filed 2024-11-07 | $12.75M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-03-31 | $9.00M 10-Q · filed 2024-10-16 | $9.00M derived: sum of 2 quarters · filed 2024-10-16 | $9.00M derived: sum of 3 quarters · filed 2024-10-16 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $0.00 derived: sum of 2 quarters · filed 2024-07-30 | $30.00M 10-K · filed 2024-07-30 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-03 | $30.00M 10-Q · filed 2024-01-03 | ||
| 2022-06-30 | $30.00M 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $81.90M derived: sum of 2 quarters · filed 2023-03-31 | $83.40M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $81.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $83.40M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $1.50M 10-Q · filed 2021-08-19 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $0.00 derived: sum of 2 quarters · filed 2021-05-24 | $7.00M 10-K/A · filed 2021-05-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $7.00M 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $7.00M 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |